Table 2.
Commercial radiopharmaceuticals currently used in clinical nuclear medicine.
| Product trade Name/code | Manufacturer/sponsor | Final dose preparationa,b | Mode of administration |
Indicationsc | |
|---|---|---|---|---|---|
| Origin | Description | ||||
| CERETEC | UK | Kit for the preparation of technetium [99mTc] exametazime injection | Simple | Intravenous | Scintigraphic localization of seizure foci in patients with temporal lobe epilepsy |
|
| |||||
| LEUCOCYTE Labelling Kit [LLK] | Australia | Kit for the preparation of technetium [99mTc] labelled leucocytes (99mTc-Sn(O)F2) | Complex | Intravenous | Image acute inflammation or infection |
|
| |||||
| MDP | Many | Kit for the preparation of technetium [99mTc] medronate injection |
Simple | Intravenous | Skeletal imaging pharmaceutical |
|
| |||||
| Indium [111In] oxine | UK, Netherlands | A diagnostic radiopharmaceutical intended for radiolabelling | Simple | Intravenous | In vitro radiolabeling of separated leukocytes and platelets which are subsequently reinjected intravenously for investigative purposes |
|
| |||||
| Gallium [67Ga] citrate injection | Many | An injection containing radioactive gallium [67Ga] | Simple | Intravenous | It may be useful in demonstrating the presence and extent of Hodgkin's disease, lymphomas, and bronchogenic carcinoma and may also be useful as an aid in detecting some acute inflammatory lesions |
|
| |||||
| Fluorodeoxyglucose [18F] injection | Many | A positron emitting radiopharmaceutical containing no-carrier added radioactive 2-deoxy-2-[18F]fluoro-D-glucose | Simple | Intravenous | Identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures, in the evaluation of malignancy in patients and identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function |
|
| |||||
| LeukoScan | USA, Germany | Kit for the preparation of 99mTc-labeled LeukoScan | Simple | Intravenous | For determining the location and extent of infection/inflammation in bone in patients with suspected osteomyelitis, including patients with diabetic foot ulcers |
|
| |||||
| Scintimun | France | Scintimun 1 mg kit for radiopharmaceutical preparation | Complex | Intravenous | For determining the location of inflammation/infection in peripheral bone in adults with suspected osteomyelitis |
|
| |||||
| Nanocoll | Italy | Kit for radiopharmaceutical preparation (99mTc-HAA) | Simple | Intravenous | Bone marrow scanning (excluding hematopoietic activity) and inflammation scanning (excluding the abdomen) |
aSimple operations involving one radioisotope reconstitution step/withdrawal of final patient dose(s); bcomplex operations involving multisteps of reconstitution/heating/other manipulations/purification/withdrawal of final patient dose(s); cfrom the Product Information Sheet.